Surgery

Trimodality Therapy Increases Survival; Immunotherapy Treatment Approved by FDA

Since mesothelioma is often difficult to treat, scientists and researchers look to combination treatments and therapies to improve chances of patients’ survival. There is no “one” treatment that is used across the board in treating mesothelioma, because patients react differently, whether it is to chemotherapy, radiation therapy, immunotherapy, or surgery.[…]

Read More »

Mesothelioma Treatments Used Alongside Surgery – A Clinical Trial

Rare and aggressive in nature, mesothelioma is often a fatal cancer mainly due to its lack of response to most treatments. Surgical options have a higher chance of success for those in the early stages of the disease, but since there is a long latency period between asbestos exposure and[…]

Read More »

Improvements in Radiation Therapies Give More Treatment Options

When it comes to different treatments for mesothelioma patients, there is no shortage of diversity, as options include chemotherapy, radiation, surgery, immune-based therapies, gene-based therapies, and more. Chemotherapy treatments cisplatin and pemetrexed are first line treatments, especially among those who do not quality for surgery. Radiation treatment is available, but[…]

Read More »

Nutritional Status and Tumor Thickness Helps Determine Mesothelioma Prognosis

The overall nutritional health of a patient suffering from mesothelioma can have major impact on how the patient will respond to treatment, which affects patient survival. To determine a patient’s nutritional factors on a more exact basis, researchers and scientists from Japan used a scoring system called Controlling Nutritional Status[…]

Read More »

Lung-Sparing Surgery Dramatically Improves Prognosis for Mesothelioma Patients

Those suffering from mesothelioma know that the prognosis is grim. The average life expectancy for someone who is recently diagnosed is only eight months. Chemotherapy is the standard treatment for mesothelioma, but in most cases, the cancer is too far advanced for chemotherapy to be effective. Surgery for mesothelioma is[…]

Read More »

Mesothelioma Awareness Day 2016

September 26, 2016, was Mesothelioma Awareness Day. This day dedicated to raising awareness for mesothelioma, was established in 2004 by the Mesothelioma Applied Research Foundation (MARF). MARF is a nonprofit organization that believes that there is a cure for mesothelioma and through education, fundraising and awareness, a cure can be[…]

Read More »

Groundbreaking Clinical Trial for Mesothelioma Patients

The researchers and scientists at the Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center excitedly announced a new clinical trial that combines immunotherapy and surgery for the treatment of mesothelioma. This is the first time that these two treatments have been combined and scientists and[…]

Read More »

Research shows both mesothelioma surgeries produce results

A recent study by United Kingdom researchers discovered when considering the mesothelioma surgery options, there is no clear choice. Cancer centers and mesothelioma doctors often disagree about which procedure to offer between extrapleural pneumonectomy  (EPP) and pleurectomy/decotication (P/D). The surgeries attempt to either remove and cure the patient or relieve[…]

Read More »